Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases

By Udhayabanu Tamilarasan   Manole Andreea   Rajeshwari Mohan   Varalakshmi Perumal   Houlden Henry   Ashokkumar Balasubramaniem  

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-05 ,pp. : 52-52

MDPI

Access to resources Recommend Favorite

Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders

By Stepien Karolina M.   Heaton Robert   Rankin Scott   Murphy Alex   Bentley James   Sexton Darren   Hargreaves Iain P.  

Journal of Clinical Medicine, Vol. 6, Iss. 7, 2017-07 ,pp. : 71-71

MDPI

Access to resources Recommend Favorite

Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family

By  

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 158-176

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Rasburicase in Anticancer Therapy-Induced Hyperuricemia

By Oldfield Vicki   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 197-199

Adis International

Access to resources Recommend Favorite

Cocaine-induced hepatotoxicity or an acquired mitochondrial defect?

By Rahman TM   Wadsworth C   Anson G   Wendon J  

Clinical Intensive Care, Vol. 15, Iss. 2-3, 2004-06 ,pp. : 61-63

Ashgate Publishing Ltd

Access to resources Recommend Favorite